These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4665739)

  • 1. [Reaction kinetics of activator formation in streptokinase-induced fibrinolysis].
    Martin M
    Verh Dtsch Ges Inn Med; 1972; 78():717-9. PubMed ID: 4665739
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on activator formation in human plasma with streptokinase. II. Quantitative activator and plasminogen measurements during continuous and intermittent streptokinase infusion.
    Martin M
    Thromb Diath Haemorrh; 1973 Nov; 30(2):393-402. PubMed ID: 4773378
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of acylated streptokinase-plasminogen complex and streptokinase in healthy volunteers.
    Prowse CV; Hornsey V; Ruckley CV; Boulton FE
    Thromb Haemost; 1982 Apr; 47(2):132-5. PubMed ID: 7048621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Binding of an acylated plasminogen activator-streptokinase complex with fibrin and the fibrinolytic response in vitro].
    Aĭsina RB; Zhitkova IuV; Varfolomeev SD
    Vopr Med Khim; 1994; 40(3):31-5. PubMed ID: 8079435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of the acylated streptokinase-plasminogen activator complex BRL 33 575 incubated with normal human plasma.
    Lämmle B; Noll G; Tran TH; Lohri A; Duckert F
    Thromb Haemost; 1984 Jul; 51(3):403-5. PubMed ID: 6548585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of formation of bovine plasminogen activator from human plasmin.
    Ling CM; Summaria L; Robbins KC
    J Biol Chem; 1965 Nov; 240(11):4213-8. PubMed ID: 4221202
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation and fibrinolysis.
    Heimburger N; Trobisch H
    Angew Chem Int Ed Engl; 1971 Feb; 10(2):85-97. PubMed ID: 4995468
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on activator formation in human plasma with streptokinase. I. Experimental studies.
    Martin M
    Thromb Diath Haemorrh; 1973 Nov; 30(2):381-92. PubMed ID: 4773377
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver and the fibrinolytic system].
    Van de Loo J
    Thromb Diath Haemorrh Suppl; 1973; 55():77-113. PubMed ID: 4612868
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The behavior of coagulation and fibrinolysis factors with different streptokinase doses].
    Poliwoda H; Krohn HP; Steuber H
    Med Lab (Stuttg); 1968 Nov; 21(11):252-61. PubMed ID: 5714595
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetic properties of the activator complexes plasmin--staphylokinase and plasmin(ogen)--streptokinase in vitro.
    Sazonova IY; Aisina RB; Muhametova LI; Varfolomeyev SD
    Biochemistry (Mosc); 1999 Jan; 64(1):66-74. PubMed ID: 9986915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Direct activator effect of streptokinase on plasminogen. Studies on plasminogen activation in relation to the concentration of urokinase and streptokinase].
    Binder B; Zarrabi Z
    Wien Med Wochenschr; 1972 Feb; 122(7):104-6. PubMed ID: 5062209
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinolysis--a review.
    Kane KK
    Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on thrombolysis with streptokinase. II. The influence of changes due to age in thrombi and whole blood clots.
    Gottlob R; Blümel G; Piza F; Brücke R; Böhmig HJ
    Thromb Diath Haemorrh; 1968 Jul; 19(3):516-25. PubMed ID: 5751633
    [No Abstract]   [Full Text] [Related]  

  • 17. The susceptibility of plasma to activation of fibrinolysis.
    Stief TW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):123-5. PubMed ID: 8457639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activator time. A method for control of activator activity during thrombolytic therapy.
    Blix S
    Scand J Haematol; 1969; 6(4):221-6. PubMed ID: 5388562
    [No Abstract]   [Full Text] [Related]  

  • 20. Approaches to the molecular chemistry of coagulation and fibrinolysis.
    Müllertz S
    Scand J Clin Lab Invest; 1968; 22(1):1-3. PubMed ID: 4236696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.